|
ALK-Abello A/S - Comparative Business Analysis Snapshot
Business Description
ALK-Abello A/S. The principal activity of the Group is developing products for diagnosis, prevention and treatment of allergies. The Group operates through one business area namely: Allergy sector. The Allergy sector operates within allergy vaccination - injection-based and drop-based vaccines, the only treatment able to cure allergy rather than just alleviate symptoms. In addition to the existing business, the Group has developed a pipeline of projects which have the potential to bring crucial, innovative change to the treatment and cure of allergy. The Group operates subsidiaries in France, Netherlands, Italy, Sweden, Germany, UK and USA, and has sales offices in China, Finland, Norway and Denmark. In 2008 the Group acquired Western Allergy Services Ltd. and allergy vacinationation activities of its former distributior in cannada.
Competitor Analysis
This analysis compares ALK-Abello A/S with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
